AI-generated influencers can effectively spread cancer prevention messages on social media at a low cost, offering a scalable solution for public health campaigns.
BioNTech says no to Phase 3 with Genmab’s bispecific antibody
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS